Topical Steroid Withdrawal Syndrome Awareness Day at the state capitol; 2/3/25; recognize
Summary
House Resolution 135 is a commemorative resolution that recognizes February 3, 2025, as Topical Steroid Withdrawal Syndrome Awareness Day at the state capitol. The resolution describes Topical Steroid Withdrawal Syndrome (TSWS), also referred to as topical steroid addiction or red skin syndrome, as a serious condition that may occur after use of topical steroids prescribed or purchased over the counter for skin conditions such as eczema, psoriasis, vitiligo, and alopecia areata.
The resolution highlights reported symptoms and consequences of TSWS, including severe skin flushing, inflammation, widespread rashes, flaking, burning, itching, prolonged recovery, and major disruptions to daily life. It also emphasizes the mental health effects associated with the condition, the lack of published research and diagnostic criteria, and the need for greater education for both healthcare providers and patients about steroid stewardship and the risks of dependence and withdrawal.
Impact
HR 135 does not amend state law, create a regulatory program, or impose duties on agencies, providers, or insurers. Its practical effect is symbolic: it designates a day of awareness at the state capitol and authorizes the House Clerk to distribute copies of the resolution to the public and press. The resolution may help elevate public and professional attention to TSWS and related patient education issues, but it has no direct statutory impact on treatment standards, prescribing rules, or benefits coverage.
Sentiment
The overall sentiment reflected in the resolution is supportive and awareness-oriented. The bill presents TSWS as a serious but underrecognized condition and frames the measure as a way to encourage education, prevention, and better understanding among patients and providers. No committee debate or recorded votes are provided, so there is no evidence of formal opposition in the available materials.
Contention
The resolution itself identifies the main areas of concern: limited research, uncertain prevalence, lack of diagnostic criteria, and possible misunderstandings between patients and healthcare providers. It also notes that providers may misinterpret symptoms as non-compliance or parental neglect, suggesting a need for better awareness. Because there are no transcripts or votes, no specific legislative controversy or organized opposition is documented in the available record.